Snapshot img

Cannabidiol (CBD) Market Size 2025-2029

The cannabidiol (CBD) market size is forecast to increase by USD 56.5 billion, at a CAGR of 24.8% between 2024 and 2029.

The CBD market is experiencing significant growth, driven primarily by the ongoing legalization and regulatory changes surrounding cannabidiol. This evolving regulatory landscape presents both opportunities and challenges for market participants. On the one hand, increasing legalization allows for broader market access, fostering growth in various end-use industries such as food and beverages, cosmetics, and pharmaceuticals. On the other hand, the high cost of CBD products poses a significant challenge for consumer adoption and market penetration. The e-commerce industry plays a crucial role in the CBD market's growth, enabling brands to reach a wider audience and offering consumers the convenience of purchasing products online.
However, the high cost of CBD products, largely due to production and extraction expenses, may limit market expansion and create barriers for smaller players. To capitalize on market opportunities and navigate challenges effectively, companies must focus on optimizing production costs, exploring alternative extraction methods, and developing innovative, competitively priced products. By addressing these challenges and leveraging the growing demand for CBD, businesses can position themselves for success in this dynamic and rapidly evolving market.

What will be the Size of the Cannabidiol (CBD) Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The CBD market continues to evolve at an unprecedented pace, with new developments and trends emerging constantly. One of the most significant areas of growth is product differentiation, as companies strive to distinguish themselves in a crowded marketplace. CBD for inflammation is a popular application, with many brands offering various forms of CBD, including capsules, gummies, and topicals. Cannabis-derived CBD and hemp-derived CBD are two distinct categories, each with its unique advantages and challenges. The legal framework surrounding CBD is also a dynamic factor, with regulations evolving to accommodate the growing industry. Bioavailability is another critical aspect, with brands investing in research to improve the efficacy of their products through advanced formulation and delivery methods.

Consumer education is essential as the market becomes more complex, with various CBD types, such as broad spectrum and full spectrum, and different extraction methods, such as CO2 and ethanol. Brand awareness and loyalty are also crucial, with companies focusing on sustainable practices, transparency, and competitive pricing strategies to attract and retain customers. CBD's applications extend beyond human health, with the pet market showing significant growth. Pricing strategies vary, with some brands adopting a direct-to-consumer model, while others rely on retail channels and wholesale distribution. Regulations continue to shape the industry, with a focus on ensuring safety and quality, particularly in the areas of labeling, clinical trials, and intellectual property.

The CBD market's continuous evolution reflects the ongoing research and innovation in this field. From CBD oil to CBD vape products, CBD for anxiety to CBD for athletes, the potential applications of CBD are vast and ever-expanding. As the industry matures, it is essential to stay informed about the latest trends, regulations, and consumer preferences to remain competitive and succeed in this dynamic market.

How is this Cannabidiol (CBD) Industry segmented?

The cannabidiol (CBD) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Source

  Marijuana
  Hemp


Distribution Channel

  Offline
  Online


End-user

  Medical
  Personal use
  Wellness


Geography

  North America

    US
    Canada
    Mexico


  Europe

    France
    Germany
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

.

By Source Insights

The marijuana segment is estimated to witness significant growth during the forecast period.

CBD, a non-psychoactive compound derived from the cannabis plant, has gained significant attention in the health and wellness industry due to its potential therapeutic benefits. Different forms of CBD products cater to various consumer preferences, including capsules, oils, topicals, edibles, vape products, and tinctures. The market for CBD continues to grow rapidly, driven by increasing consumer awareness and acceptance, favorable legal frameworks, and expanding product innovation.

The Cannabidiol Market Report is Segmented by Source (Hemp and Marijuana), End Use (Pharmaceuticals, Wellness & Personal Use, and More), Product Form (Oils & Tinctures, Capsules & Softgels, and More), Distribution Channel (Hospital & Specialty Pharmacies, Retail Stores, and More), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Natural wellness revolution! $9.81B CBD market expanding across pharmaceuticals, beauty care & food. Uncover winning strategies from Aurora Cannabis, Canopy Growth & top innovators

Global Cannabidiol Market size was valued at around USD 22.7 billion in 2023 and is projected to grow at a CAGR of around 19.21% during the forecast period 2024-30. increasing popularity of functional CBD products is one of the key trends shaping the growth of cbd market.

The global cannabidiol (CBD) market size is projected to grow from USD 13.14 billion in 2025 to USD 51.43 billion by 2033, exhibiting a CAGR of 18.6%.
Report Scope:

The Cannabidiol (CBD) Oil Market Report is Segmented by Source Type (Hemp-Derived, Marijuana-Derived), Product Form (Capsules & Softgels and More), Sales Type (B2B, B2C [Offline Retail Pharmacies and More]), End-Use Sector (Cosmetics & Beauty and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Discover the flourishing Europe CBD market projected to grow at a 24.57% CAGR by 2028. Legalization and increasing acceptance drive the market's expansion.

The global Cannabidiol (CBD) market is projected to reach a valuation of approximately USD 47 billion by 2033, growing at a compound annual growth rate (CAGR) of 21% from 2025 to 2033.

The size of the Cannabidiol CBD Infused Beverage Market market was valued at USD 2.3 Billion in 2024 and is projected to reach USD 9.89 Billion by 2033, with an expected CAGR of 23.16% during the forecast period. Recent developments include: Recent developments in the Cannabidiol (CBD) Infused Beverage Market have showcased a growing interest among major companies. Curaleaf continues to expand its product line, focusing on enhancing consumer experiences. Diageo has been exploring the cannabis beverage sector, signaling a potential entry into this emerging market. Lagunitas Brewing Company has successfully launched its cannabis-infused beverages, garnering positive consumer feedback. Flow Beverage Corp is seeing increased demand for its CBD-infused drinks as health-conscious consumers drive market growth. Aurora Cannabis is actively launching new products, while CocaCola is keeping an eye on the CBD market for future opportunities. In recent merger activities, Constellation Brands has made a substantial investment in Canopy Growth Corporation, reflecting confidence in the cannabis-infused beverage segment. AB InBev has also been investigating partnerships in this category to diversify its portfolio. The market is experiencing significant growth, driven by an increasing valuation of companies such as Tilray Brands and Molson Coors Beverage Company, which are actively exploring CBD innovations. Overall, the CBD-infused beverage market is evolving swiftly, with companies adapting to changing consumer preferences and regulatory landscapes.. Key drivers for this market are: Health-conscious consumer demand, Growing legalization of cannabis; Innovative product formulations; Direct-to-consumer sales channels; Rising interest in functional beverages. Potential restraints include: Increasing health consciousness, Regulatory challenges; Growing product diversification; Rising consumer demand; Enhanced distribution channels.

The size of the CBD Market was valued at USD 24.78 billion in 2023 and is projected to reach USD 78.47 billion by 2032, with an expected CAGR of 17.90% during the forecast period. Recent developments include: June 2021: For about USD 60 million, The Valens Company finalized the purchase of Green Roads. The acquisition provides The Valens Company with a well-established Green Road network that allows it access to the U.S. CBD industry., October 2020: Researchers and faculty at the Medical College of Georgia and the Dental College of Georgia have shown how cannabidiol (CBD) can cause significantly less lung damage and inflammation. They have also demonstrated how CBD can raise oxygen levels for disorders connected to adult respiratory problems.. Key drivers for this market are: Growing Research And Development Activities And Financial Support By Various Private And. Potential restraints include: Adverse Effects Associated With Cannabis 25, Stringent Government Policies 25. Notable trends are: Increasing the use of cannabidiol (CBD) for medicinal purposes will boost the market growth.

Europe CBD Product market size is USD 2344.56 million in 2024 and will expand at a compound annual growth rate (CAGR) of 14.7% from 2024 to 2031.

By 2026, the cannabidiol (CBD) market size in Canada is expected to be *** million U.S. dollars, a slight increase from the *** million dollars in expected CBD sales in 2022. This statistic illustrates the projected CBD market size in Canada from 2022 to 2026.

It is expected that U.S. consumer sales of cannabidiol (CBD) will reach around 1.8 billion U.S. dollars by 2022, which would represent a significant increase from around half a billion U.S. dollars in 2018. Following a similar trajectory, sales of legal cannabis in the U.S. are projected to hit 23 billion U.S. dollars in 2025.

What are the benefits of CBD? Cannabidiol is a naturally occurring substance found in cannabis. However, CBD does not cause any of the psychoactive effects that come from another active ingredient found in the plant: tetrahydrocannabinol (THC). The health benefits of the plant extract continue to be examined, and the World Health Organization states that CBD exhibits no effects indicative of any abuse or dependence potential. The CBD retail industry is already flourishing, with a wide range of products marketed as treatments for chronic pain, anxiety, and depression.

CBD in the USA: sales by state With estimated sales of around 730 million U.S. dollars, California had the biggest CBD market in the United States in 2019. Regulations concerning the use of cannabidiols are yet to be clearly defined, and state authorities are having to answer numerous questions about its legality. It is, however, currently illegal under U.S. law to market CBD by adding it to a food or labeling it as a dietary supplement. As of March 2020, the FDA has approved only one CBD product: Epidiolex. The prescription drug is used to treat two rare and severe forms of epilepsy.

In 2023, the sales value of cannabidiol (CBD) in Japan exceeded ** million U.S. dollars. The CBD market was projected to grow continuously in the following years, reaching almost ** million dollars in 2027. Cannabis is a controlled drug in Japan, for which recreational and medicinal uses are prohibited. While CBD products without the psychoactive component tetrahydrocannabinol (THC) can be legally distributed, the ban on cannabis cultivation makes imports the main procurement channel of the derivative.

The global cannabidiol (CBD) market is experiencing robust growth, projected to reach $567.2 million in 2025 and exhibiting a remarkable Compound Annual Growth Rate (CAGR) of 27.1% from 2025 to 2033. This expansion is driven by several factors. Increasing consumer awareness of CBD's potential therapeutic benefits for anxiety, pain relief, and sleep disorders fuels demand across diverse applications. The legalization and decriminalization of cannabis in various regions are significantly contributing to market accessibility. Furthermore, the expanding research and development efforts focused on CBD's efficacy and safety profile are further boosting investor confidence and driving market growth. The market's segmentation reflects this diverse application landscape, with significant contributions from the pharmaceuticals, food, and cosmetics industries. Hemp-derived CBD currently dominates the market due to its legal accessibility and lower cost compared to marijuana-derived CBD. However, the latter segment is expected to witness significant growth as regulations evolve. Key players such as Kazmira, KND Labs, and Aurora Cannabis are actively shaping the market through product innovation and strategic expansions. The geographic distribution of the CBD market reflects a concentration in North America, initially driven by early adoption and supportive regulatory environments in the United States and Canada. However, growing acceptance in Europe and the Asia-Pacific region, particularly in countries with emerging cannabis regulations, presents substantial untapped potential. While challenges remain, such as inconsistent regulations across different jurisdictions and concerns regarding product quality and standardization, the overall market outlook for CBD remains exceptionally positive, driven by continuous innovation, expanding consumer base, and the potential for broad therapeutic applications. The market is expected to continue its trajectory of strong growth well into the forecast period (2025-2033), benefiting from technological advancements and growing consumer understanding of CBD's diverse applications.

Discover the booming full-spectrum CBD market! Explore a $2.916 billion industry (2025) with a projected high CAGR, driven by pain relief, anxiety reduction, and more. Learn about key players, trends, and regional variations in this comprehensive market analysis. Invest wisely in this rapidly expanding sector.

The global CBD hemp oil market is experiencing robust growth, driven by increasing consumer awareness of its potential health benefits and the expanding legalization of cannabis-derived products. While precise market sizing data for 2025 is unavailable, leveraging industry reports and the stated study period (2019-2033), a reasonable estimate places the 2025 market value at approximately $2.5 billion USD. This is based on an assumed, steady growth rate considering the market's maturity and regulatory hurdles in certain regions. Key growth drivers include the increasing prevalence of anxiety and chronic pain, the rising popularity of holistic wellness approaches, and the growing acceptance of CBD as a natural remedy. Market trends show a shift towards high-quality, organically sourced CBD products, along with innovative delivery methods like topical creams and edibles. However, regulatory uncertainty in some countries and inconsistent product quality pose significant restraints to market expansion. The market is segmented by product type (oils, capsules, topicals, etc.), application (anxiety, pain relief, sleep disorders, etc.), and distribution channel (online, retail stores, pharmacies). Leading companies like Cannavest, Pharmahemp, and Endoca are actively innovating and expanding their product lines to meet the evolving consumer demand. Looking ahead to 2033, the market is projected to maintain substantial growth. Continued scientific research validating the therapeutic benefits of CBD, combined with strategic marketing and product diversification by market players, will fuel expansion. The growth, however, will be influenced by ongoing regulatory changes. Regions with progressive cannabis policies, such as North America and certain parts of Europe, are expected to dominate the market share. The focus will be on transparency and quality control as consumers become increasingly discerning about the source and purity of their CBD products. Companies are likely to invest heavily in research and development to improve product efficacy and explore new applications for CBD hemp oil.

Discover the booming prescription Cannabidiol (CBD) oil market projected to reach $6 billion by 2033. This analysis explores market drivers, restraints, key players like Jazz Pharmaceuticals and Tilray, and regional market share, offering valuable insights for investors and industry professionals. Learn more about CAGR, market size, and future trends in prescription CBD.

The size of the Broad Spectrum Cannabidiol CBD Oil Market market was valued at USD 8.32 Billion in 2024 and is projected to reach USD 23.49 Billion by 2033, with an expected CAGR of 15.98% during the forecast period. Recent developments include: The Broad Spectrum Cannabidiol (CBD) Oil Market is witnessing significant developments, with companies like CV Sciences and Medterra expanding their product ranges in response to increasing consumer demand for wellness products. Joy Organics has also recently launched new formulations to cater to the growing interest in natural remedies, further fueling competition. Alongside these innovations, the market is seeing substantial growth, with analysts predicting increased valuations for firms such as Charlotte's Web and CBDistillery, influenced by rising consumer awareness regarding the health benefits of CBD. Acquisition activity is on the rise as well; for instance, Cannabidiol Life has made strategic partnerships to enhance its distribution channels, while NuLeaf Naturals has been noted for exploring potential collaborations to expand its market reach. The overall regulatory landscape for CBD products is evolving as governments are gradually implementing measures that recognize the legitimacy of CBD oil, offering more clarity for businesses. This creates a conducive environment for firms like HempFusion and R+R Medicinals to penetrate new markets effectively and increase their share in the growing landscape. The ongoing shifts are indicative of a robust market trajectory for the broad spectrum CBD oil sector.. Key drivers for this market are: Growing health and wellness trends, Increased demand for natural remedies; Expansion of product applications; Rise in e-commerce distribution; Legalization and regulatory support.. Potential restraints include: increasing consumer awareness, regulatory landscape changes; growing health and wellness trends; rising product innovation; expanding distribution channels.

CBD Market Outlook

According to our latest research, the global CBD market size in 2024 stands at USD 8.2 billion, reflecting robust expansion driven by increasing consumer acceptance and adoption of cannabidiol-based products. The industry is experiencing a strong compound annual growth rate (CAGR) of 21.5% from 2025 to 2033. By the end of 2033, the CBD market is forecasted to reach a value of USD 57.1 billion. This impressive growth trajectory is primarily fueled by the rising demand for natural wellness products, expanding legalization across several countries, and ongoing research supporting the therapeutic benefits of CBD.

One of the key growth factors propelling the CBD market is the increasing awareness and acceptance of CBDÂ’s potential health benefits among consumers. As scientific research continues to validate the efficacy of CBD in managing various health conditions such as anxiety, chronic pain, inflammation, and epilepsy, consumers are increasingly turning to CBD as an alternative or complementary therapy. This shift in consumer behavior is further supported by educational initiatives from both governmental and private organizations, which are dispelling myths and misconceptions about CBD, leading to greater mainstream adoption. Additionally, the proliferation of information through digital platforms and social media has played a pivotal role in educating consumers about the safe and effective use of CBD products, thereby expanding the addressable market.

Another significant driver of the CBD market is the evolving regulatory landscape, particularly the gradual legalization and decriminalization of hemp-derived CBD products across major markets such as North America and Europe. The passage of the 2018 Farm Bill in the United States, which legalized the cultivation of industrial hemp and the extraction of hemp-derived CBD, has been a watershed moment for the industry. This regulatory shift has encouraged a wave of investments, innovation, and new product launches, as businesses seek to capitalize on the burgeoning demand for CBD-infused products. Moreover, the increasing clarity and harmonization of CBD regulations across regions are reducing barriers to entry, fostering cross-border trade, and enabling multinational companies to expand their footprint in the global CBD market.

The diversification of product offerings and the entry of established players from adjacent industries are also catalyzing market growth. The CBD market has evolved beyond traditional oils and tinctures to encompass a wide array of formats, including edibles, topicals, beverages, capsules, and even pet products. This product innovation is attracting a broader consumer base, including those who may have been hesitant to try CBD in its original forms. Furthermore, collaborations between CBD manufacturers and companies in the food, beverage, cosmetics, and pharmaceutical sectors are resulting in the development of novel products with enhanced efficacy and appeal. As a result, the CBD market is not only expanding in terms of volume but also in terms of consumer demographics and use cases, driving sustained growth over the forecast period.

From a regional perspective, North America continues to dominate the global CBD market, accounting for the largest share in terms of revenue and product innovation. The United States, in particular, is at the forefront, benefiting from a favorable regulatory environment, high consumer awareness, and a thriving ecosystem of manufacturers and distributors. Europe follows as the second-largest market, with countries such as the United Kingdom, Germany, and Switzerland witnessing increased legalization and consumer acceptance. Meanwhile, the Asia Pacific region is emerging as a high-growth market, driven by changing regulations, rising health consciousness, and increasing investments in research and development. Latin America and the Middle East & Africa are also showing promising growth potential, albeit from a smaller base, as regulatory frameworks evolve and consumer interest in natural wellness products rises.